ArticleScientific reports2026

Higher lymph node burden predicts greater chemotherapy benefit in resected pancreatic ductal adenocarcinoma: evidence from 22,045 patients.

Jun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.